Recommended Pages at pharmabiz.com
Eisai, Minophagen Pharma conclude bexarotene licensing agreement
pharmabiz.com — “Eisai, Minophagen Pharma conclude bexarotene licensing agreement” View full resource at pharmabiz.com
Most Recently Shared on April 3, 2012 at 1:16 pm By:
Eisai signs over Targretin rights in Asia, ME and Eastern Europe to Minophagen, for up-front + milestones http://t.co/KqQFuAxl #pharma
BRNI researchers report new clues for cause of Alzheimer's disease
pharmabiz.com — “BRNI researchers report new clues for cause of Alzheimer's disease” View full resource at pharmabiz.com
Most Recently Shared on March 19, 2012 at 6:59 am By:
Alzheimer's Reading Room is the number one source of life news for the entire Alzheimer's community. Our goal is to Educate, sometimes Entertain, and Empower Alzheimers caregivers and their families worldwide.
" /> Alzheimer's Reading Room Health Advocate
BRNI researchers report new clues for cause of Alzheimer's disease http://t.co/vMFlf4rM #alzheimers #news
Infants treated for cancer tend to have delayed developmental milestones: NIH researchers
pharmabiz.com — “Infants treated for cancer tend to have delayed developmental milestones: NIH researchers” View full resource at pharmabiz.com
Most Recently Shared on March 13, 2012 at 6:17 am By:
Amir Abdullah Al-Bey Health Blog
Infants treated for cancer tend to have delayed developmental milestones: NIH ... http://t.co/b3Z6ZeeE
Pharmabiz :: Chelsea gets new patent for use of droxidopa in fibromyalgia
pharmabiz.com — “Chelsea gets new patent for use of droxidopa in fibromyalgia” View full resource at pharmabiz.com
Most Recently Shared on September 9, 2011 at 12:27 am By:
Chelsea gets new patent for use of droxidopa in fibromyalgia - pharmabiz.com http://t.co/FuTm5r4
Pharmabiz :: Multiple rules and inadequate funding are sustainable management of medicinal plants: Dr Narayana
pharmabiz.com — “Multiple rules and inadequate funding are sustainable management of medicinal plants: Dr Narayana” View full resource at pharmabiz.com
Most Recently Shared on September 8, 2011 at 3:46 am By:
Multiple rules and inadequate funding mar sustainable management of medicinal ... http://t.co/0dJwqA1
Pharmabiz :: Alexza resubmits its NDA application for schizophrenia
pharmabiz.com — “Alexza resubmits its NDA application for schizophrenia” View full resource at pharmabiz.com
Most Recently Shared on August 9, 2011 at 6:56 am By:
Peter H Brown Doctor and Psychologist
Alexza resubmits its NDA application for schizophrenia http://bit.ly/qwZ3Q8 #bipolar
Pharmabiz :: Medical devices industry needs more R&D boost from government: D L Pandya
pharmabiz.com — “Medical devices industry needs more R&D boost from government: D L Pandya” View full resource at pharmabiz.com
Most Recently Shared on July 28, 2011 at 7:31 am By:
Drugs and Devices OW OW Health
Medical devices industry needs more R&D boost from government: DL Pandya - pharmabiz.com: Medical dev... http://bit.ly/qGC02S #MedDevice
Pharmabiz :: Positive top-line results for Pfizer’s Lyrica in phase 3 study of patients with fibromyalgia in Japan
pharmabiz.com — “Positive top-line results for Pfizer’s Lyrica in phase 3 study of patients with fibromyalgia in Japan” View full resource at pharmabiz.com
Most Recently Shared on July 8, 2011 at 12:59 pm By:
Positive top-line results for Pfizer's Lyrica in phase 3 study of patients ... - pharmabiz.com http://bit.ly/qLahPI
Pharmabiz :: As many as 230 drugs targeting diabetes under development by PhRMA member companies
pharmabiz.com — “As many as 230 drugs targeting diabetes under development by PhRMA member companies” View full resource at pharmabiz.com
Most Recently Shared on July 5, 2011 at 3:09 am By:
As many as 230 drugs targeting #diabetes under development by PhRMA member companies http://bit.ly/kurvgj "cure" not mentioned
Pharmabiz :: Rcadia Medical Imaging receives four US patents covering technology for automated analysis of coronary CT angiography
pharmabiz.com — “Rcadia Medical Imaging receives four US patents covering technology for automated analysis of coronary CT angiography” View full resource at pharmabiz.com
Most Recently Shared on July 1, 2011 at 10:53 am By:
Philips Medical News Health Business
Rcadia Medical Imaging receives four US patents covering technology for ... http://bit.ly/inLIeE - #imaging
Pharmabiz :: Allergy Therapeutics submits MAA for Grass MATA MPL Dossier in Switzerland
pharmabiz.com — “Allergy Therapeutics submits MAA for Grass MATA MPL Dossier in Switzerland” View full resource at pharmabiz.com
Most Recently Shared on April 11, 2011 at 1:43 pm By:
Allergy Therapeutics submits MAA for Grass MATA MPL Dossier in Switzerland http://bit.ly/fKYHuf
Pharmabiz :: Harbor BioSciences wraps up phase I/II a prostate cancer study
pharmabiz.com — “Harbor BioSciences wraps up phase I/II a prostate cancer study” View full resource at pharmabiz.com
Most Recently Shared on February 10, 2011 at 1:57 pm By:
Harbor BioSciences wraps up phase I/II a prostate cancer study http://bit.ly/gvjUzq
New topical gel (DSC127) from Derma Science showing great results on DFUs - just finished Phase 2 testing...
pharmabiz.com — “New topical gel (DSC127) from Derma Science showing great results on DFUs - just finished Phase 2 testing...” View full resource at pharmabiz.com
Most Recently Shared on February 8, 2011 at 7:37 pm By:
Hai-En Peng, DPM Podiatrist and Doctor
New topical gel (DSC127) from Derma Science showing great results on DFUs - just finished Phase 2 testing... http://fb.me/KJ7tczjL
Pharmabiz :: Aveo Pharma gets USAN name for novel, internally discovered anti-HGF/c-MET pathway antibody
pharmabiz.com — “Aveo Pharma gets USAN name for novel, internally discovered anti-HGF/c-MET pathway antibody” View full resource at pharmabiz.com
Most Recently Shared on February 8, 2011 at 6:39 pm By:
Kidney Cancer Health Executive
Aveo Pharma gets USAN name for novel, internally discovered anti-HGF/c-MET pathway antibody http://bit.ly/hpqKcB
Pharmabiz :: EMA recommends marketing authorization for sanofi-aventis' Jevtana for prostate cancer
pharmabiz.com — “EMA recommends marketing authorization for sanofi-aventis' Jevtana for prostate cancer” View full resource at pharmabiz.com
Most Recently Shared on January 25, 2011 at 8:56 am By:
EMA recommends marketing authorization for sanofi-aventis' Jevtana for ... http://bit.ly/dHUedd
